Three dividend stocks to watch in volatile markets

Uncertainty is not just something investors read about in headlines; it shows up in day-to-day portfolio decisions when prices swing and narratives change. In volatile markets, investors often shift from asking what might rise next to focusing on what they can comfortably hold if conditions remain messy for a while.

During these periods, some investors tend to gravitate toward companies that are straightforward, consistent, and able to return cash while they wait. Below are three names highlighted for different reasons, along with the specific developments and valuation or deal details cited in the source material.

Weis Markets: Dividend consistency and valuation

Weis Markets operates about 200 grocery stores under its own banner, primarily in Pennsylvania and nearby states. The company declared a quarterly dividend of $0.34 per share in February 2026, which the source describes as yielding approximately 2% on an annualized basis.

The article also points to context around the stock’s trading level: it recently crossed below its 200-day moving average, a technical signal that has historically attracted value-oriented buyers. Weis shares trade at a price-to-earnings (P/E) ratio of roughly 15.6, below the broader consumer retailing industry average of 19.2.

On supply chain exposure, the source notes that Weis’s domestic, regional supply chain implies limited direct tariff exposure because the majority of what its stores stock is sourced domestically.

Ingles Markets: Dividend plus an activist catalyst

Ingles Markets (IMKTA) is a Southeast-focused supermarket chain headquartered in Asheville, North Carolina. The company operates hundreds of stores across the Carolinas, Georgia, Tennessee, Virginia, and Alabama. The source highlights that Ingles also owns and operates its own milk and ice cream processing facility, describing this as a form of vertical integration.

In March, Ingles declared a quarterly cash dividend of $0.165 per share on its Class A shares.

The article also describes an activist shareholder situation: investment firm Summer Road LLC is challenging the board ahead of the April 30 shareholder meeting. The source frames activism at a smaller, undervalued retailer as potentially catalytic, while cautioning that investors should be wary and “slowly” invest as the challenge plays out.

Prestige Consumer Healthcare: Acquisition expands brand portfolio

Prestige Consumer Healthcare (PBH) owns a portfolio of over-the-counter health and personal care brands, including Clear Eyes, Summer's Eve, Chloraseptic, and Dramamine. The source characterizes these as need-based purchases that can remain relevant during downturns.

In March, Prestige announced its biggest move in years: a definitive agreement to acquire the Breathe Right brand and associated assets from Foundation Consumer Healthcare for $1.045 billion. The source specifies this as approximately $900 million net of an anticipated $150 million in tax benefits.

The acquired portfolio is described as generating about $200 million in trailing-12-month revenue. Breathe Right is expected to become Prestige’s largest brand and provide a platform in the “better breathing” wellness category, with meaningful international reach.

Impact and investor takeaway

The source argues that uncertainty does not eliminate durable businesses; instead, it can make investors more selective about what they trust. Weis Markets, Ingles Markets, and Prestige Consumer Healthcare are presented as fitting different criteria—durability, cash flow, and relevance under tougher conditions—while the article emphasizes that volatility and company-specific risks remain.

Rather than rushing, the author says these are the types of names they are comfortable watching closely and slowly building into if the market offers an opportunity.